Lishomwa C. Ndhlovu - Jan 3, 2024 Form 4 Insider Report for CytoDyn Inc. (CYDY)

Role
Director
Signature
/s/ Antonio Migliarese, Attorney-in-Fact for Lishomwa C Ndhlovu
Stock symbol
CYDY
Transactions as of
Jan 3, 2024
Transactions value $
$0
Form type
4
Date filed
1/5/2024, 09:02 PM
Previous filing
Sep 8, 2022
Next filing
Oct 30, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYDY Non-qualified stock option (right to buy) Award $0 +800K $0.00 800K Jan 3, 2024 Common Stock 800K $0.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 466,662 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from January 2024 through May 2024.